Suppr超能文献

三种结直肠癌筛查方法的使用障碍——来自一项全国性调查的数据

Barriers to utilization of three colorectal cancer screening options - Data from a national survey.

作者信息

Zhu Xuan, Parks Philip D, Weiser Emily, Jacobson Debra J, Limburg Paul J, Finney Rutten Lila J

机构信息

Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, 200 First Street SW, Rochester, MN 55905, USA.

Exact Sciences Corporation, 441 Charmany Drive, Madison, WI 53719, USA.

出版信息

Prev Med Rep. 2021 Jul 29;24:101508. doi: 10.1016/j.pmedr.2021.101508. eCollection 2021 Dec.

Abstract

Colorectal cancer (CRC) screening continues to be underutilized in the United States. A better understanding of existing barriers is critical for improving uptake of, and adherence to, CRC screening. Using data from a population-based panel survey, we examined barriers to utilization of three commonly used screening options (FIT/gFOBT, mt-sDNA, and screening colonoscopy) and assessed differences by socio-demographic characteristics, healthcare access, and health status. Data were obtained from a questionnaire developed by the authors and implemented through a U.S. national panel survey conducted in November 2019. Among 5,097 invited panelists, 1,595 completed the survey (31.3%). Analyses were focused on individuals ages 50-75 at average risk for CRC. Results showed that among respondents who reported no prior CRC screening with FIT/gFOBT, mt-sDNA, or colonoscopy, the top barriers were lack of knowledge (FIT/gFOBT: 42.1%, mt-sDNA: 44.9%, colonoscopy: 34.7%), lack of provider recommendation (FIT/gFOBT: 32.1%, mt-sDNA: 27.3%, colonoscopy: 18.6%), and suboptimal access (FIT/gFOBT: 20.8%, mt-sDNA: 17.8%, colonoscopy: 26%). Among participants who had used one or two of the screening options, the top barriers to FIT/gFOBT and mt-sDNA were lack of provider recommendation (31.6% & 37.5%) and lack of knowledge (24.6% & 25.6%), while for colonoscopy top barriers were psychosocial barriers (31%) and lack of provider recommendation (22.7%). Differences by sex, race/ethnicity, income level, and health status were observed. Our research identified primary barriers to the utilization of three endorsed CRC screening options and differences by patient characteristics, highlighting the importance of improving CRC screening education and considering patient preferences in screening recommendations.

摘要

在美国,结直肠癌(CRC)筛查的利用率仍然很低。更好地了解现有障碍对于提高CRC筛查的接受率和依从性至关重要。利用基于人群的小组调查数据,我们研究了三种常用筛查方法(粪便免疫化学试验/愈创木脂粪便潜血试验、甲基化SEPT9基因检测和筛查性结肠镜检查)的使用障碍,并评估了社会人口特征、医疗保健可及性和健康状况方面的差异。数据来自作者编制的一份问卷,并通过2019年11月进行的美国全国小组调查实施。在5097名受邀小组成员中,1595人完成了调查(31.3%)。分析集中于年龄在50 - 75岁、患CRC平均风险的个体。结果显示,在报告此前未使用粪便免疫化学试验/愈创木脂粪便潜血试验、甲基化SEPT9基因检测或结肠镜检查进行CRC筛查的受访者中,主要障碍是缺乏了解(粪便免疫化学试验/愈创木脂粪便潜血试验:42.1%,甲基化SEPT9基因检测:44.9%,结肠镜检查:34.7%)、缺乏医生建议(粪便免疫化学试验/愈创木脂粪便潜血试验:32.1%,甲基化SEPT9基因检测:27.3%,结肠镜检查:18.6%)以及可及性欠佳(粪便免疫化学试验/愈创木脂粪便潜血试验:20.8%,甲基化SEPT9基因检测:17.8%,结肠镜检查:26%)。在使用过一两种筛查方法的参与者中,粪便免疫化学试验/愈创木脂粪便潜血试验和甲基化SEPT9基因检测的主要障碍是缺乏医生建议(31.6%和37.5%)以及缺乏了解(24.6%和25.6%),而结肠镜检查的主要障碍是心理社会障碍(31%)和缺乏医生建议(22.7%)。观察到了性别、种族/民族、收入水平和健康状况方面的差异。我们的研究确定了三种认可的CRC筛查方法使用中的主要障碍以及患者特征方面的差异,凸显了改善CRC筛查教育以及在筛查建议中考虑患者偏好的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d9d/8350367/d8e0b17994af/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验